List of works - Javier Vaquero

Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.

scientific article published on 13 May 2013

Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta.

scientific article

Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.

scientific article

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

scientific article

E-cadherin, guardian of liver physiology

scientific article published on 12 November 2014

Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

scientific article

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

scientific article published on 20 April 2016

Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.

scientific article published on 30 July 2013

FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver.

scientific article published on 10 January 2013

IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma.

scientific article

Involvement of UDP-Glucuronosyltransferases and Sulfotransferases in the Excretion and Tissue Distribution of Resveratrol in Mice

scientific article published on 12 December 2017

Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.

scientific article published in March 2016

MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.

scientific article published on 18 September 2017

No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

scientific article

Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.

scientific article published on 3 July 2017

Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.

scientific article published on 9 January 2017

Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance

scientific article published on 01 May 2019

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

scientific article published on 18 December 2018

Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.

scientific article published on 8 August 2012

List of works by Javier Vaquero

Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.

Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta.

Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

E-cadherin, guardian of liver physiology

Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.

FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver.

IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma.

Involvement of UDP-Glucuronosyltransferases and Sulfotransferases in the Excretion and Tissue Distribution of Resveratrol in Mice

Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.

MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.

No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.

Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.

Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma

Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.